NL-OMON24467招募中不适用
Quantification of Circulating tumor DNA to assess treatment response in metastatic prostate cancer patients
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 95
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Histologically or cytologically confirmed adenocarcinoma of the prostate.
- •- Measurable metastatic lesion(s) according to PCWG2 and/or RECIST 1.1 criteria
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Quantification of Circulating tumor DNA derived Structural variants to assess treatment response in metastatic prostate cancer patientsprostate carcinoma10038364prostate cancerNL-OMON43524Erasmus MC, Universitair Medisch Centrum Rotterdam285
进行中（未招募）
1 期
CIRCULATE - A TRIAL TO IMPROVE CARE OF PATIENTS AFTER COLON TUMOR SURGERY, BASED ON AN INNOVATIVE MARKER: CIRCULATING TUMOR DNAstage II colon cancer, after tumour resectionEUCTR2019-000935-15-FRCentre Hospitalier Universitaire (CHU) de Dijon1,980
招募中
不适用
Circulating tumor DNA (ctDNA) analyses as a predictive marker for cancer treatment in solid tumorsKCT0008188Chonnam National University Hospital Hwasun Hospital100
招募中
不适用
Circulating tumor DNA for minimal residual disease in acute myeloid leukemia after allogeneic hematopoietic stem cell transplant: a multi-center prospective study.Acute Myeloid Leukemia, Myelodysplastic SyndromesJPRN-UMIN000033003Kanto Study Group for Cell Therapy70
已完成
Unknown
Combined analysis of circulating tumor DNA status and Histotyping score by deep learning in curatively resected colorectal cancerColorectal cancerJPRN-UMIN000049638ational Cancer Center Hospital East5,000